Mcp- Sf

Metoclopramide Hydrochloride, the active ingredient in Mcp- Sf, is a dopamine D2 receptor antagonist presented as a subcutaneous preparation for injection use. It is employed to treat nausea, vomiting, gastroparesis and migraine‑associated nausea in adult patients. GNH USA supplies Mcp- Sf as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoclopramide Hydrochloride is used to manage conditions involving nausea, vomiting and delayed gastric emptying.

- Nausea and vomiting: reduces the frequency and severity of episodes caused by chemotherapy, surgery or other triggers. - Gastroparesis: enhances gastric motility to improve stomach emptying in patients with delayed gastric transit. - Migraine‑associated nausea: alleviates nausea that accompanies acute migraine attacks.

Metoclopramide Hydrochloride may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Drowsiness - Fatigue - Restlessness or akathisia - Diarrhea - Headache - Dry mouth

Serious or Rare Side Effects: - Extrapyramidal symptoms (e.g., dystonia, parkinsonism) - Tardive dyskinesia with prolonged use - Neuroleptic malignant syndrome - Severe allergic reactions (anaphylaxis, skin rash) - Hyperprolactinemia leading to hormonal disturbances - Depression or suicidal thoughts

Before prescribing Metoclopramide Hydrochloride, clinicians should consider several safety aspects. - Assess for movement disorders: monitor patients for extrapyramidal symptoms, especially during the first days of therapy. - Review cardiac history: avoid in patients with known QT‑interval prolongation or significant arrhythmias. - Consider renal function: dose adjustment may be required in severe renal impairment. - Avoid in known hypersensitivity: discontinue immediately if an allergic reaction occurs. - Pregnancy and lactation: use only when the potential benefit justifies the potential risk to the fetus or infant. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Metoclopramide Hydrochloride can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antipsychotics (e.g., haloperidol): increased risk of severe extrapyramidal reactions. - CNS depressants (e.g., benzodiazepines, barbiturates): additive sedation and respiratory depression. - CYP2D6 inhibitors (e.g., quinidine, fluoxetine): may raise metoclopramide plasma concentrations.

Moderate Interactions (Monitor Closely): - Opioids (e.g., morphine, codeine): heightened nausea and potential for reduced analgesic effect. - Selective serotonin reuptake inhibitors (e.g., sertraline, citalopram): possible serotonin syndrome when combined. - Alcohol: enhanced central nervous system depression and dizziness.